Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Webcast: Precision Management of Late Endocrine Effects in Cancer Survivors
  • CME
  • MOC
  • CE

From ENDO 2021, learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.
Wassim Chemaitilly, MD
Laurie E. Cohen, MD
Danielle N. Friedman, MD, MS
Steven G. Waguespack, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits
ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s)
Registered Nurses: 1.5 Nursing contact hours
Pharmacists: 1.5 contact hours (0.15 CEUs)
Released: March 22, 2021 Expiration: February 28, 2022

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize the common root causes of late endocrine effects due to cancer treatment in survivors of childhood cancer and the importance of lifelong monitoring for their development
  • Review hypothalamic pituitary disorders in childhood cancer survivors
  • Apply practical strategies to diagnosing thyroid disease in pediatric cancer patients and survivors
  • Discuss the challenges of obesity and diabetes mellitus in cancer survivors


Provided by the Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Information on this Educational Activity


Wassim Chemaitilly, MD

Associate Member and Director

Division of Endocrinology
St. Jude Children's Research Hospital
Memphis, Tennessee

Wassim Chemaitilly, MD, has disclosed he has no relevant financial relationships during the content development process for this activity.
Laurie E. Cohen, MD

Director, Neuroendocrinology Program
Director, Growth Program
Division of Endocrinology
Boston Children’s Hospital
Associate Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts

Laurie E. Cohen, MD, reported the following relevant financial relationship(s) during the content development process for this activity: Research Investigator, Pfizer, Inc.; Speaker, Novo Nordisk; Other, Sandoz
Danielle N. Friedman, MD, MS

Pediatric Long-Term Follow-Up Program
Department of Pediatrics
Memorial Sloan Kettering Cancer Center
New York, New York

Danielle N. Friedman, MD, MS, reported the following relevant financial relationship(s) during the content development process for this activity: Advisory Board Member, Fennec
Steven G. Waguespack, MD

Division of Internal Medicine
Department of Endocrine Neoplasia and Hormonal Disorders
University of Texas MD Anderson Cancer Center
Houston, Texas

Steven G. Waguespack, MD, has disclosed he has no relevant financial relationships during the content development process for this activity.

Physician Continuing Medical Education

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

For questions about obtaining Nursing credit, please contact Sophia Kelley at skelley@clinicaloptions.com.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-21-017-L01-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.